Paraganglioma and Pheochromocytoma click to access explanations in the original CAP template

Useful information to be included from the case notes:
1. Clinical history
2. Functional status
--- Biochemically functioning
----- Metanephrine and / or adrenaline
----- Normetanephrine and / or noradrenaline
----- 3-Methoxytyramine and / or dopamine
--- Nonfunctional (biochemically non-functioning)
3. Tumor Scintigraphy or PET Avidity
- DOTATATE or DOTATOC PET
- 123I-metaiodobenzylguanidine (MIBG) scintigraphy
4. Anatomical location from imaging
5. Tumor sizes from imaging

Selecting multiple small hot spots (at least 500 tumor cells) from different hot spot regions of the tumor rather than a single larger area of the same tumor are recommended.

Using 22 mm eyepiece at 40x objective, count active proliferative areas for 42 fields (equals 10 mm2), divide by 5 to get mitotic count for 2 mm2

Applied to all sympathetic paragangliomas and pheochromocytomas. Currently there is no defined TNM Classification for parasympathetic paragangliomas and composite paragangliomas / pheochromocytomas but users can apply the TNM staging below (based on the tumor size cutoff of 5 cm and the status of invasion) to facilitate uniform data collection.